Quantinuum’s (QNT) Buy Rating Reiterated at Rosenblatt Securities

Quantinuum (NASDAQ:QNT)‘s stock had its “buy” rating reissued by equities research analysts at Rosenblatt Securities in a report released on Thursday, Benzinga reports. They presently have a $155.00 price objective on the stock. Rosenblatt Securities‘s price target points to a potential upside of 336.62% from the company’s current price.

QNT has been the subject of a number of other reports. Zacks Research raised Quantinuum to a “hold” rating in a research note on Tuesday, June 30th. Craig Hallum started coverage on Quantinuum in a research note on Monday, June 29th. They issued a “buy” rating and a $100.00 price target on the stock. Yorkville Ives started coverage on Quantinuum in a report on Monday, October 5th. They set an “outperform” rating and a $60.00 price objective on the stock. Wall Street Zen lowered Quantinuum from a “hold” rating to a “sell” rating in a report on Saturday, July 4th. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $100.00 price objective on shares of Quantinuum in a research report on Wednesday, August 12th. Thirteen research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $94.23.

Quantinuum Trading Down 8.2%

NASDAQ QNT traded down $3.15 during trading hours on Thursday, hitting $35.50. 743,975 shares of the stock were exchanged, compared to its average volume of 2,308,754. The company has a market cap of $9.35 billion and a P/E ratio of -126.79. Quantinuum has a 12-month low of $33.02 and a 12-month high of $86.79. The stock has a 50-day moving average of $48.70.

Quantinuum (NASDAQ:QNT) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.28) EPS for the quarter, missing analysts’ consensus estimates of ($0.26) by ($0.02). The company had revenue of $8.00 million for the quarter. On average, analysts expect that Quantinuum will post -4.76 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in QNT. SBI Securities Co. Ltd. lifted its position in shares of Quantinuum by 52.8% during the 3rd quarter. SBI Securities Co. Ltd. now owns 6,778 shares of the company’s stock valued at $326,000 after acquiring an additional 2,343 shares during the period. IFP Advisors Inc grew its holdings in shares of Quantinuum by 1,150.0% in the 3rd quarter. IFP Advisors Inc now owns 1,250 shares of the company’s stock worth $60,000 after acquiring an additional 1,150 shares during the period. Counterpoint Mutual Funds LLC acquired a new stake in shares of Quantinuum in the 3rd quarter worth approximately $408,000. Vontobel Holding Ltd. acquired a new stake in shares of Quantinuum in the 3rd quarter worth approximately $743,000. Finally, Parisi Gray Wealth Management increased its stake in Quantinuum by 508.7% in the 3rd quarter. Parisi Gray Wealth Management now owns 18,717 shares of the company’s stock valued at $900,000 after purchasing an additional 15,642 shares in the last quarter.

About Quantinuum

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.